El Hachem May, Diociaiuti Andrea, Bonamonte Domenico, Brena Michela, Lospalluti Lucia, Magnoni Cristina, Neri Iria, Peris Ketty, Tadini Gianluca, Zambruno Giovanna
Dermatology Unit and Genodermatosis Unit, Translational Pediatrics and Clinical Genetics Research Area, Bambino Gesù Children's Hospital-IRCCS, Piazza Sant'Onofrio, 4, 00165, Rome, Italy.
Department of Precision and Regenerative Medicine and Ionian Area, Unit of Dermatology, University of Bari "Aldo Moro", Policlinico of Bari, Bari, Italy.
Orphanet J Rare Dis. 2025 Mar 16;20(1):128. doi: 10.1186/s13023-025-03635-1.
Recessive dystrophic epidermolysis bullosa (RDEB) is a rare and severe mucocutaneous fragility disorder due to mutations in the COL7A1 gene encoding collagen VII, the major constituent of anchoring fibrils essential for epithelial adhesion. RDEB is characterized by unremitting blistering, chronic painful wounds and fibrotic scarring that results in hand and foot pseudosyndactyly, microstomia, and esophageal strictures. RDEB complications include nutritional compromise, chronic anemia, failure to thrive, delayed puberty, osteoporosis, and renal involvement. In addition, early onset cutaneous squamous cell carcinomas (cSCC) represent the first cause of premature death. Despite recent progress in wound care, disease management still relies on symptomatic and preventive measures. No clinical practice guidelines specifically focused on the care of RDEB are currently available. The present multidisciplinary consensus recommendations were generated following a modified Delphi method with the aim to provide healthcare professionals with practical statements on RDEB management from birth to adulthood.
Ten experts from six Italian EB reference centers developed 86 statements based on existing clinical practice guidelines and consensus recommendations for EB, literature data, and personal expertise. A multidisciplinary group of 30 members, representative of all major specialties relevant to RDEB management, participated to the anonymous online voting process. All statements reached consensus (> 75% agreement) at first voting round. Statements are divided into four major areas: (1) diagnosis, (2) neonatal age and infancy, (3) from childhood to adulthood, and (4) transversal age-independent issues, each of the last three comprising multiple domains of care. In particular, the section on patient care from childhood to adults deals with measures for management of wounds, gastrointestinal, eye and renal involvement, nutritional compromise, anemia, hand and foot deformities, cSCC, delayed puberty and osteoporosis, sexuality, pregnancy and delivery. Transversal issues comprise: pain and itch management, patient care in the operating theatre, physiotherapy and occupational therapy, therapeutic patient education and psychosocial support.
The proposed practical and synthetic recommendations cover all major issues in the management of patients with RDEB from birth to adulthood. They can represent a useful tool to support hospital healthcare personnel as well as primary care physicians in the complex multidisciplinary management of RDEB.
隐性营养不良性大疱性表皮松解症(RDEB)是一种罕见且严重的黏膜皮肤脆性疾病,由编码胶原蛋白VII的COL7A1基因突变引起,胶原蛋白VII是上皮黏附所必需的锚定原纤维的主要成分。RDEB的特征是持续性水疱、慢性疼痛性伤口和纤维化瘢痕形成,导致手足假性并指、小口畸形和食管狭窄。RDEB的并发症包括营养状况不佳、慢性贫血、生长发育迟缓、青春期延迟、骨质疏松和肾脏受累。此外,早期发生的皮肤鳞状细胞癌(cSCC)是过早死亡的首要原因。尽管伤口护理最近取得了进展,但疾病管理仍依赖于对症和预防措施。目前尚无专门针对RDEB护理的临床实践指南。本多学科共识性建议是采用改良的德尔菲法制定的,旨在为医疗保健专业人员提供从出生到成年期RDEB管理的实用声明。
来自六个意大利大疱性表皮松解症参考中心的十位专家根据现有的大疱性表皮松解症临床实践指南和共识性建议、文献数据以及个人专业知识制定了86条声明。一个由30名成员组成的多学科小组,代表了与RDEB管理相关的所有主要专业,参与了匿名在线投票过程。所有声明在第一轮投票中均达成共识(>75%的同意率)。声明分为四个主要领域:(1)诊断,(2)新生儿期和婴儿期,(3)从儿童期到成年期,以及(4)与年龄无关的横向问题,后三个领域中的每个领域都包含多个护理方面。特别是,从儿童期到成年期的患者护理部分涉及伤口管理、胃肠道、眼睛和肾脏受累、营养状况不佳、贫血、手足畸形、cSCC、青春期延迟和骨质疏松、性、妊娠和分娩的措施。横向问题包括:疼痛和瘙痒管理、手术室中的患者护理、物理治疗和职业治疗、治疗性患者教育和心理社会支持。
所提出的实用且综合的建议涵盖了从出生到成年期RDEB患者管理中的所有主要问题。它们可以成为支持医院医护人员以及初级保健医生进行RDEB复杂多学科管理的有用工具。